ERBB2 and ovarian cancer: The flow cytometry results showed that HER2 CAR-Ms significantly promoted the differentiation of CD3+ T cells into CTLs (Fig. 2F) after engulfing the SKOV3 ovarian cancer cells with high HER2 expression compared with the control group.